Milestone scientific receives notice of allowance for european patent related to combination of nerve stimulation and dps dynamic pressure sensing technology® to optimize needle tip location in ultrasound-guided pnb procedures

Roseland, n.j., march 10, 2021 (globe newswire) -- milestone scientific inc. (nyse american:mlss), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has received notice of allowance from the european patent office (epo) combining minimum intensity of nerve stimulation (mis) and real-time injection pressure (ip) monitoring utilizing milestone's compuflo® instrument and associated dps dynamic pressure sensing technology® to optimize needle tip location in ultrasound-guided peripheral nerve block (pnb) procedures. the technology was developed in conjunction with dr. olivier choquet from the lapeyronie university hospital montpellier france, a renowned expert in peripheral nerve block procedures, and dr. mark hochman, d.d.s., inventor and clinical director for milestone scientific.
MLSS Ratings Summary
MLSS Quant Ranking